Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in double digits.
The top line moved up 11% year-over-year to $1.56 billion during the three-month period, driven by a marked increase in da Vinci procedures and installed bases.
Adjusted earnings remained unchanged at $1.19 per share. Net income, including special items, came in at $324 million or $0.90 per share, compared to $380.5 million or $1.04 per share last year.
Worldwide da Vinci procedures rose approximately 20% year-over-year and the company shipped 305 da Vinci Surgical Systems. At the end of the quarter, it had a total of 7,364 da Vinci Surgical systems installed base, which is up 13%.
Prior Performance
Most Popular
TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel
TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic chimeric antigen receptor (CAR) T-cell therapy products for
Cintas Corp. (CTAS) Q3 2023 earnings and revenue increase
Uniform rental company Cintas Corporation (NASDAQ: CTAS) on Wednesday announced financial results for the third quarter of 2023, reporting higher earnings and revenues. At $2.19 billion, third-quarter revenues were up
Infographic: Micron (MU) reports net loss for Q2; revenue down 53%
Micron Technology Inc. (NASDAQ: MU) slipped to a loss in the second quarter of 2023 from a profit last year, hurt by a sharp fall in revenues. The chipmaker reported
